Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microphthalmia/Transcription Factor E (MiT/TFE) Pathways in Pulmonary Diseases: Current Evidence and Emerging Mechanisms. | Cells | 2026 | 42041586 | PubTator, text mining | PubMed |
| Renal tumors harboring FLCN mutations: Case series from clinical practice. | Hum Pathol | 2026 | 42000053 | PubTator, text mining | PubMed |
| Unexpected Cervical Lymph Node Metastasis Revealing TFE3-Rearranged Renal Cell Carcinoma: Intraoperative Cytologic Clues to an Occult Renal Primary. | Diagn Cytopathol | 2026 | 41999268 | PubTator, text mining | PubMed |
| Features and molecular genetic study of low-grade oncocytic tumor of the kidney. | Ann Diagn Pathol | 2026 | 41996739 | PubTator, text mining | PubMed |
| Solid Pseudopapillary Neoplasms of the Pancreas with Delayed Ovarian Metastasis During Pregnancy: A Case Report and Literature Review. | Int J Womens Health | 2026 | 41994298 | PubTator, text mining | PubMed |
| GRASP55 maintains lysosome function by controlling sorting of lysosomal enzymes at the Golgi. | EMBO Rep | 2026 | 41991615 | PubTator, text mining | PubMed |
| PEComas: current concepts in diagnosis, molecular pathways, and emerging treatments. | Oncologist | 2026 | 41964900 | PubTator, text mining | PubMed |
| Newcastle disease virus exploits Golgi stress and Golgiphagy to promote ferroptosis. | Autophagy | 2026 | 41961065 | PubTator, text mining | PubMed |
| [Clinicopathological features of TSC/mTOR mutation-associated renal cell carcinoma with leiomyomatous stroma: report of nine cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41956743 | PubTator, text mining | PubMed |
| Robot-assisted partial nephrectomy for TFE3-rearranged renal cell carcinoma: a case report and literature review. | Front Oncol | 2026 | 41939471 | PubTator, text mining | PubMed |
| Improving the diagnosis of renal tumours of young people through integrated molecular analysis. | J Cancer Res Clin Oncol | 2026 | 41933220 | PubTator, text mining | PubMed |
| A radiomics-based interpretable model to distinguish Xp11.2/TFE3 translocation renal cell carcinoma and common types of renal cell carcinoma on CT images. | Cancer Treat Res Commun | 2026 | 41930555 | PubTator, text mining | PubMed |
| Ultrasonographic Findings and Clinical Characteristics of TFE3-Rearranged Renal Cell Carcinomas in Adults. | J Clin Ultrasound | 2026 | 41906257 | PubTator, text mining | PubMed |
| Beyond clear cell: Rare histologic and molecular variants of renal cell carcinoma. | Urol Oncol | 2026 | 41904096 | PubTator, text mining | PubMed |
| TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances. | Cancers (Basel) | 2026 | 41899560 | PubTator, text mining | PubMed |
| NHE1-Mediated Metabolic Reprogramming in Cancer. | Metabolites | 2026 | 41893344 | PubTator, text mining | PubMed |
| TFE3-rearranged PEComa-like neoplasm harboring a novel ZBED6::TFE3 fusion with an unusual immunophenotype. | Am J Clin Pathol | 2026 | 41891890 | PubTator, text mining | PubMed |
| Integrated Clinicopathologic and Genetic Characterization of Renal TFE3-Rearranged PEComa with Melanin Pigmentation: A Case Series and Comprehensive Literature Review. | Int J Surg Pathol | 2026 | 41885733 | PubTator, text mining | PubMed |
| Peripheral inflammation mediates midbrain Lrrk2 kinase activity via Rab32 expression. | bioRxiv | 2026 | 41846967 | PubTator, text mining | PubMed |
| The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RCC. | Neoplasia | 2026 | 41843980 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=4